Roth Capital Raises Price Target on Lannett (LCI) Following Acquisition of Kremers Urban Pharmaceuticals
Go back to Roth Capital Raises Price Target on Lannett (LCI) Following Acquisition of Kremers Urban Pharmaceuticals| LANNETT COMP (NYSE: LCI) | Delayed: 0.69 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.69 | 52 Week High | $44.49 | |||
| Open | $117.23 | 52 Week Low | $16.75 | |||
| Day High | $0.69 | P/E | 1.35 | |||
| Day Low | $0.69 | EPS | $0.51 | |||
| Volume | 584,457 | |||||
